What is Legionnaires' disease? The symptoms of the potentially deadly disease to watch for
The serious form of pneumonia is caused by Legionella bacteria and approximately one in 10 people who are sickened will die due to complications.
So, what symptoms should people look out for and how is Legionnaires' disease transmitted? Here's what to know.
What is Legionnaires' disease?
Legionnaires' disease is a severe form of pneumonia – or lung inflammation usually caused by a bacterial, viral or fungal infection. In the recent New York City outbreak, the disease is caused by Legionella bacteria. The disease is transmitted by inhaling the bacteria from water or soil.
What are the causes of this disease?
Legionella bacteria is responsible for most cases of Legionnaires' disease. The bacterium is often found outdoors but the Mayo Clinic says it rarely causes infections there.
It is also possible to get the disease from home plumbing, with most outbreaks occurring in large buildings, 'perhaps because complex systems allow the bacteria to grow and spread more easily,' the clinic noted.
Previous outbreaks have been linked to:
• Hot tubs and whirlpools
• Cooling towers in air conditioning systems
• Hot water tanks and heaters
• Decorative fountains
• Swimming pools
• Birthing pools
• Drinking water
The infection can also be transmitted through aspiration, which occurs when liquids accidentally enter your lungs, and through soil.
Legionnaires' disease usually develops between two to 14 days after exposure to legionella bacteria, according to the Centers for Disease Control and Prevention.
Some of the symptoms include:
• Headache
• Muscle aches
• A fever
By the second or third day, you may develop other signs and symptoms such as:
• A cough that might bring up mucus and sometimes blood. As many as 50% of patients can have phlegm as well.
• Shortness of breath
• Chest pain
• Confusion
• Nausea and or vomiting
• Diarrhea
'Although Legionnaires' disease primarily affects the lungs, it occasionally can cause infections in wounds and in other parts of the body, including the heart,' the Mayo Clinic said. Possible complications include lung failure and death.
There is also a mild form of Legionnaires' disease known as Pontiac fever which can produce a fever, chills and muscle aches. This fever does not affect the lungs and usually clears up within two to five days.
Who is most at risk?
In most cases, not everyone exposed to the bacteria becomes sick. But, exposure means some people are at a higher risk of infection.
Those people include smokers. People with weakened immune systems, those with chronic lung diseases or other chronic conditions, and people over 50 are also at greater risk.
Is the disease contagious?
The disease is not contagious and you cannot get it from another person, according to the Cleveland Clinic.
How is it diagnosed?
A simple x-ray of a person's chest can tell if someone has pneumonia, but other tests are necessary to see if Legionella is responsible.
Those include a urine or lab test that takes fluid from the lung or phlegm.
How is the disease treated?
There is no vaccine for Legionnaires' disease. If diagnosed with the disease, you may need to go to the hospital. Medical staff may be able to give patients antibiotics or administer oxygen through a face mask or a breathing machine.
When you are showing signs of recovery, the doctor might prescribe antibiotic medication that usually lasts for between one and three weeks.
'Any pneumonia can cause a lingering type of fatigue,' Dr. Ben Singer, a pulmonary and critical care specialist at Northwestern Medicine, told The New York Times. 'People can take a long time to get better.'
The key lies in prevention. People should clean any water-using devices and flush faucets, according to the Centers for Disease Control and Prevention.
Buildings and devices at an increased risk for growth should have a water management program, the agency said.
The bacteria can also grow in vehicles' windshield wiper fluid tanks.
'To prevent growth and spread of Legionella, only use genuine windshield cleaner fluid and follow the vehicle manufacturer recommendations, if available,' the agency advised.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
26 minutes ago
- Reuters
US FDA approves Jazz Pharma's drug for rare brain tumor
Aug 6 (Reuters) - The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' (JAZZ.O), opens new tab drug to treat diffuse midline glioma, a rare and aggressive tumor, in adults and children aged one year and older. This marks the first FDA approval of a systemic therapy for diffuse midline glioma with a specific mutation that has progressed after previous treatments, the agency said. Diffuse midline glioma (DMG) is a rare and aggressive brain tumor that primarily affects children and young adults. It develops in the brain's and spinal cord's midline structures, such as the brainstem, thalamus, and spinal cord. Jazz Pharmaceuticals acquired the drug in March through its $935 million purchase of Chimerix.
Medical News Today
34 minutes ago
- Medical News Today
What to know about ataxia telangiectasia
Ataxia telangiectasia (AT) is a rare genetic condition that people inherit from their parents. AT affects the part of the brain that controls movement and coordination. Ataxia is when a person has difficulty controlling their voluntary muscle movements. This can lead to difficulty with balance, coordination, speech, and fine motor tasks such as writing, typing, and buttoning refers to tiny, spider-like blood vessels under the skin that have become widened or broken and are now visible. These blood vessels are typically more visible around the nose, cheeks, chin, legs, chest, and describes when a person experiences a combination of ataxia and telangiectasia. This article discusses AT further, including a more detailed look into the causes, symptoms, diagnosis, treatment, and potential outlook for this ataxia-telangiectasia mutated (ATM) gene is responsible for creating the ATM protein. This protein plays a critical role in detecting DNA damage, repairing DNA, signaling cells to stop dividing while under repair, and shutting down cells with extensive in the ATM gene can occur, which can change how the cells work or prevent them from working at all. AT can occur when a person inherits one mutation of the ATM gene from each parent. Healthcare professionals typically describe this pattern of inheritance as autosomal article from 2023 suggests that if both parents carry one copy of the ATM gene mutation, a child may have a:25% chance of developing AT50% chance of carrying the ATM gene mutation but not developing AT25% chance of inheriting two working copies of the geneA person who carries only one copy of the gene mutation will not typically experience any symptoms of AT. However, it is possible that any children they may have will inherit the gene mutation, and they are more likely to develop cancer. »Learn more:Autosomal inheritance: Definition, types, and conditionsSymptomsAT typically appears in early childhood, often before 5 years of age. AT typically affects the nervous system, immune system, and the spine, which can lead to a number of symptoms, including:Movement and coordination issues: Children with AT can experience unsteady walking, a lack of balance, and difficulty coordinating with speech: As AT progresses, a person may experience slurred speech and difficulty with eye movements: An individual with AT may experience difficulty coordinating eye movements, or oculomotor changes: A person with AT may experience small, blue, red, or purple spider-like blood vessels around the eyes, cheeks, and ears. Immune system issues: People with AT may have a weakened immune system, which can increase the risk of infections, particularly in the lungs and physical changes: A person with AT may experience other symptoms such as premature graying of the hair, fatigue, and delayed physical and sexual research from 2019 suggests that a child with an immune deficiency, such as AT, may be more at risk of developing cancer. The most common types of cancer related to AT are acute lymphocytic leukemia and diagnose AT, a healthcare professional may assess symptoms, take a full medical history, and perform several tests. A healthcare professional will typically look for early symptoms, such as difficulty with balance and coordination, and blood vessels appearing on the skin and are several tests a healthcare professional may use to diagnose AT, including:blood tests to detect low levels of certain immune cells and antibodiesgenetic testing to confirm whether a person carries both copies of the ATM gene mutationimaging scans, such as an MRI, to assess any damage to the part of the brain that controls coordination and movementeye tests to assess the movement of the eyesTreatmentResearch is ongoing to find new treatments that target the underlying causes of AT. However, there is currently no cure for AT or a way to slow down the speed at which the condition progresses. However, a healthcare professional can help a person manage symptoms and improve overall quality of life in several ways. For example: Physical therapy may help a person maintain flexibility, balance, and coordination for as long as therapy may help a person address difficulties with breathing, speaking, and swallowing. Boosting the immune system with nutrition, high doses of vitamins, antioxidants, and gamma-globulin AT is a progressive condition, symptoms typically worsen over time. This can affect mobility, coordination, and the immune system. By the time a person reaches adolescence, they may require mobility aids, such as a wheelchair.A person with AT will typically experience a weakening of the immune system, which can increase the chances of developing infections. Therefore, a healthcare professional may regularly monitor people with AT to check for signs of with AT may also be more at risk of developing certain types of cancer. A healthcare professional will typically perform regular screenings so that they can start any necessary treatment severity of the ATM gene mutation can influence a person's life expectancy. Typically, people with AT live into early individual outlooks can vary depending on a person's overall health and other factors. For example, an individual with a later onset and slower progression of AT may live until they are approximately 50 to 60 years old. A person should contact a healthcare professional to learn more about their individual is a rare, genetic condition that can occur when a person inherits one ATM gene mutation from each parent. AT typically affects balance, coordination, the nervous system, the immune system, and the spine. Symptoms can include difficulty with movement, issues with speech, trouble swallowing, and small visible blood vessels on the skin and eyes. A healthcare professional will typically diagnose AT by assessing symptoms, taking a full medical history, and performing several tests. There is currently no cure for AT. However, management options such as physical therapy, speech therapy, and immune system support can improve overall quality of should contact a healthcare professional if they or a child in their care is experiencing symptoms that may indicate AT. A doctor can make an accurate diagnosis and recommend appropriate treatment, if necessary.
The Guardian
an hour ago
- The Guardian
RFK Jr's health department to halt $500m in mRNA vaccine research
The US Department of Health and Human Services said on Tuesday it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives. The unit, Biomedical Advanced Research and Development Authority, helps companies develop medical supplies to address public health threats, and had provided billions of dollars for development of vaccines during the Covid-19 pandemic. HHS said the wind-down includes cancellation of a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans and the right to purchase the shots, as previously reported in May. The US health agency said it was also rejecting or canceling multiple pre-award solicitations, including proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone and others. In total, the affected projects are worth 'nearly $500 million', the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move 'to preserve prior taxpayer investment'. This is the latest development under US health secretary Robert F Kennedy Jr, a longtime vaccine skeptic who has been making sweeping changes to reshape vaccines, food and medicine policies. 'We reviewed the science, listened to the experts, and acted,' Kennedy said in a statement. Kennedy said the HHS is terminating these programs because data show these vaccines 'fail to protect effectively against upper respiratory infections like COVID and flu', but did not offer scientific evidence. 'We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate,' Kennedy said. The controversial announcement came as Covid is currently on the rise again in the US and children will soon be returning to school from the summer break, while many Americans will be planning to seek fall booster shots for annual updated protection against Covid. The risks of a fresh Covid wave are compounded by new vaccine restrictions from the Trump administration. 'If you're vaccinated against Covid-19, you're less likely to get infected,' Andrew Pekosz, a virologist at Johns Hopkins University, said, before the latest announcement from the health secretary on Tuesday evening. Take-up of Covid boosters has already been relatively low. 'We haven't gotten a lot of people vaccinated for the past few years, and with the current recommendations changing, it's even less likely,' Pekosz said. HHS on Tuesday said the latest decision follows a comprehensive review of mRNA-related investments initiated during the Covid-19 public health emergency. Peter Hotez, a pediatrician who directs the Center for Vaccine Development at Texas Children's Hospital, criticized the HHS announcement on Tuesday. It will 'promote their pseudoscience agenda and weaken our nation's biosecurity', he said to CNN. 'The mRNA technology, like all biotechnologies, has strengths and weaknesses, but for a pandemic situation with a new and previously unknown pathogen, or for cancer vaccines and immunotherapeutics it has distinct advantages. HHS under Mr Kennedy is telling us that we should no longer look to the federal government for innovation in biomedicine. The states are on their own,' he added. Since taking office, Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy – firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through Donald Trump's Operation Warp Speed – a public-private partnership led by Barda that poured billions into companies to accelerate development. The technology's pioneers, Katalin Karikó and Drew Weissman, were awarded the 2023 Nobel prize in medicine for their work contributing 'to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times' The Associated Press and Reuters contributed reporting
